Bydureon BCise 2 mg, Depot-lnjektionssuspension in einem Autoinjektor
7680675030019
CH-67503
Depot-lnjektionssuspension in einem Autoinjektor
Fiches Amavita / Sun Store / Coop Vitality
Article details
- Package size
- 4
- Selling units
- 4
- Measure
- Stück
- Galenic form
- Depot-lnjektionssuspension in einem Autoinjektor
- Galenic group
- Unknown
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
exenatidum
|
2.0 MG | Substance | Wirkstoff (Principe actif) |
|
saccharum
|
- | Substance | HNIDK |
|
poly(lactidum-co-glycolidum) 50/50 (0.40 - 0.49 dl/g)
|
- | Substance | HNIDK |
|
triglycerida media
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 114.90
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/02/2021
Authorization holder
AstraZeneca AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 67503
- Drug name
- Bydureon BCise, Depot-lnjektionssuspension in einem Autoinjektor
- Galenic form
- DEPI
- ATC Code
- A10BJ01
- Authorization status
- Revoked/Withdrawn
- Dispensing category
- B
- First authorization
- 24/09/2020
- Authorization expiration date
- 01/07/2026
- IT Number
- 07.06.
- Domain
- Human medicine
Package details
- Description (FR)
- BYDUREON BCise Depot 2 mg auto-injecteur 4 pce
- Description (DE)
- BYDUREON BCise Depot 2 mg Autoinjektor 4 Stk
- Market launch
- 24/09/2020
- Market withdrawal
- 30/06/2026
- Narcotic (BTM)
- No